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Summary statement 
Kidney and fat expression QTL mapping in rat models of spontaneously-occurring insulin 
resistance associated with either diabetes or hypertension reveals conserved gene expression 
regulation suggesting shared etiology of disease phenotypes. 
 
Abstract 
To define renal molecular mechanisms that are affected by permanent hyperglycemia and 
may promote phenotypes relevant to diabetes nephropathy, we carried out linkage analysis of 
genome-wide gene transcription in kidney of F2 offspring from the Goto-Kakizaki (GK) rat 
model of type 2 diabetes and normoglycemic Brown Norway (BN) rats. We mapped 2526 
statistically significant expression quantitative trait loci (eQTLs) in the cross. Over 40% of 
eQTLs mapped in the close vicinity of the linked transcripts, underlying possible cis-
regulatory mechanisms of gene expression. We identified eQTL hotspots on chromosomes 5 
and 9 regulating the expression of 80-165 genes, sex or cross direction effects, and enriched 
metabolic and immunological processes by segregating GK alleles. Comparative analysis 
with adipose tissue eQTLs in the same cross showed that 496 eQTLs, as well as top enriched 
biological pathways, are conserved in the two tissues. Extensive similarities in eQTLs 
mapped in the GK and in the spontaneously hypertensive rat (SHR) suggest a common 
etiology of disease phenotypes common to the two strains, including insulin resistance which 
is a prominent pathophysiological feature in both GK and SHR. Our data shed light on shared 
and tissue specific molecular mechanisms that may underlie etiological aspects of insulin 
resistance in the contexts of spontaneously occurring hyperglycemia and hypertension. 
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Introduction 
 
Transcriptome-based molecular phenotyping provides detailed information on the expression 
of individual genes and biological pathways. Variation in transcript abundance can be 
mapped to the genome at expression quantitative trait loci (eQTL). The genetic control of 
gene transcription in mammals has been reported in various organs from preclinical models 
of human chronic diseases using experimental crosses (Davis et al., 2012; Kaisaki et al., 
2016; van Nas et al., 2010), recombinant congenic strains (Hubner et al., 2005; Petretto et al., 
2006), congenic strains (Dumas et al., 2016; Kaisaki et al., 2016) recombinant congenic 
strains (Lee et al., 2006) and mice of the collaborative cross (Aylor et al., 2011). eQTL 
mapping in humans has progressed from whole blood and cell systems (Dixon et al., 2007; 
Fairfax et al., 2012; Grundberg et al., 2012) to multiple post-mortem organs in control 
individuals (Battle et al., 2017), which were used to identify genes and biological pathways 
causing chronic diseases through computational integration with genome wide association 
study (GWAS) data (Gamazon et al., 2018). 
However, this strategy does not account for expected organ-specific variation in gene 
expression in disease conditions, which require access to biopsies from the affected tissues 
that are often impossible to collect in large groups of phenotypically homogeneous patients 
and healthy controls. In addition, the genetic basis of several diseases remains poorly 
characterised through GWAS. Diabetes nephropathy is a typical example of a complex 
genetic disease condition where causative genes have not been robustly mapped in humans 
through GWAS (Ahlqvist et al., 2015) and where the identification of contributing molecular 
mechanisms is therefore essential. These limitations underline the importance of preclinical 
models of human chronic diseases to accurately define tissue specific genetic control of gene 
transcription in standardised experimental conditions. 
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The Goto-Kakizaki (GK) rat is a model of type 2 diabetes mellitus, which spontaneously 
exhibits biochemical and histological evidence of nephropathy (Janssen et al., 2004). It was 
produced over many generations of breeding outbred Wistar rats using glucose intolerance as 
the sole criterion for selecting breeders (Goto et al., 1976) in order to progressively enrich the 
genome of offspring in naturally occurring polymorphisms contributing to impaired glucose 
homeostasis, whilst integrating alleles promoting increased susceptibility, as well as possibly 
resistance, to diabetes endophenotypes and associated complications (Bihoreau et al., 2017). 
We and others have derived intercrosses between GK and normoglycemic Brown Norway 
(BN) rats to comprehensively map genes responsible for the control of glucose tolerance, 
insulin secretion and adiposity (Gauguier et al., 1996), islet morphology (Finlay et al., 2010), 
lipid metabolism (Argoud et al., 2006), proteinuria (Nobrega et al., 2009), plasma 
metabolomic variables (Dumas et al., 2007) and adipose tissue gene transcription (Kaisaki et 
al., 2016). 
Here, we characterised the genetic architecture of renal gene expression in chronic diabetes 
through the mapping of kidney eQTL in a GKxBN F2 cross. We identified similarities in the 
genetic architecture of gene transcription regulation in kidney and adipose tissue and 
conserved eQTL genes in the GK and spontaneously hypertensive rat (SHR), suggesting 
common molecular mechanisms and shared genetic etiology of pathophysiological 
phenotypes. These data provide detailed information of genomic regulation in the diabetic 
kidney which can point to individual genes and biological pathways involved in the 
etiopathogenesis of human diabetic nephropathy and insulin resistance. 
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Methods 
Animals 
The GKxBN F2 cross (n=123) previously derived to map QTLs for pathophysiological 
phenotypes (Gauguier et al., 1996), metabolomic variables (Dumas et al., 2007) and adipose 
tissue eQTLs (Kaisaki et al., 2016) was used for kidney eQTL mapping. The cohort consisted 
of 60 males and 63 females generated from two reciprocal crosses of 55 F2 rats originating 
from a GK female and 68 F2 rats originating from a BN female (Figure 1). At six months, 
animals were fasted overnight and killed by terminal anaesthesia. The right kidney was 
isolated, snap frozen in liquid nitrogen and stored at -80C until RNA preparation. 
RNA preparation 
Total RNA was prepared from 100mg of frozen kidney using the RNeasy® 96 Universal 
Tissue kit (Qiagen, Crawley, UK) as previously described (Kaisaki et al., 2016). Frozen 
tissue samples were homogenised in QIAzol Lysis Reagent using Qiagen’s Tissue Lyser. 
Total RNA was purified and eluted in 90µl of RNase-free water. RNA concentrations were 
determined using a NanoDrop spectrophotometer and RNA integrity was assessed using an 
Agilent 2100 Bioanalyser (Agilent Technologies, Waldbronn, Germany). 
Illumina Bead Array hybridisation, scanning and data processing 
Kidney gene transcription profiling was performed as previously described (Kaisaki et al., 
2016) using Sentrix®BeadChipRatRef-12v1 Whole-Genome Gene Expression Arrays 
(Illumina Inc., San Diego, CA), which contain 22,523 oligonucleotide probes (replicated on 
average 30 times) allowing quantification of transcript levels for 21,910 genes. Double-
stranded cDNA and purified biotin-labelled cRNA were synthesised from 300ng high quality 
total RNA using the Illumina®TotalPrep RNA amplification kit (Ambion Inc., Austin, TX). 
cRNA concentrations were determined using a NanoDrop spectrophotometer and cRNA 
quality and integrity were assessed on an Agilent 2100 Bioanalyser (Agilent Technologies, 
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Waldbronn, Germany). 750ng of each biotinylated cRNA was used for hybridisation onto the 
arrays. BeadChip arrays were scanned on the Illumia® Bead Array Reader (Illumina Inc., San 
Diego, CA) and data were analysed using the Illumina® Bead Studio Application software 
before undergoing comprehensive statistical analysis. Quality control parameters were: 0 ≤ G 
sat ≤ 1; Green 95 Percentile (GP95) for consistency between arrays (around 2000); GP5 
background level in range of low 100 or below. Prior to array analysis, data from 757 
Illumina oligonucleotides, which carry DNA variants between GK and BN (Kaisaki et al., 
2016) were removed. We also withdrew probes that detected only background signal (ie. 
Illumina detection score <0.5 in >50% of samples). Microarray data processing was carried 
out using normexp background correction and quantile normalization (Shi et al., 2010). 
Microarray experiments were compliant with MIAME (Minimum Information About a 
Microarray Experiment) and both protocol details and raw data have been deposited in 
ArrayExpress (http://www.ebi.ac.uk/arrayexpress/) under the accession number E-MTAB-
969. 
Genetic mapping of expression QTLs in the F2 (GKxBN) cross 
eQTL analysis was performed using the R-qtl software package (Broman et al., 2003) as 
previously described (Kaisaki et al., 2016) based on genetic maps constructed in the cross 
(Wilder et al., 2004). The Haley-Knott regression method was used for genome scans (Haley 
and Knott, 1992). We used sex and cross direction as additive covariates in our models to 
account for effects of sex and lineage on gene expression (Solberg et al., 2004). Permutation 
tests (n=1,000) were carried out to determine genome wide significance threshold for each 
transcript. QTLs with a genome-scan adjusted p-value <0.05 were considered as significant. 
Regression model with sex and cross direction as additive covariants was as in (Kaisaki et al., 
2016). To detect sex x genotype interactions, QTL mapping analyses were also carried out 
using regression models containing sex as interactive covariates. 
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
D
M
M
 •
 A
cc
ep
te
d 
m
an
us
cr
ip
t
(Hi) yi =  + cci + ssi + ggi +sigi + i 
With cci denoting the effect of the cross, ssi denoting the effect of sex, ggi denoting the 
effect of the genotype and sigi denoting the interaction of sex x genotype. To obtain evidence 
for interactions between QTLs and sex, Hi was compared to the additive model Ha. This 
results in LODf: 
LODf = LODi – LODa 
To detect cross x genotype interactions (cross direction effects, CDE), we included cross 
direction as an interaction term. 
Pathway analyses 
Pathway analyses of transcriptome data were performed as previously described (Kaisaki et 
al., 2016) to determine functional categories enriched in the eQTL-controlled genes in the F2 
cross. A hypergeometric test was used on gene ontology terms and KEGG pathways 
associated with gene sets against the background of genes with detectable expression (Falcon 
and Gentleman, 2007). 
 
Results 
 
Genetic mapping of genome-wide gene transcription control in the diabetic kidney in 
(GKxBN) F2 rats 
We have previously shown that adult rats (7 month-old) of our GK colony exhibit varying 
degrees of thickening of the glomerular basement membrane and mild mesangial 
extracellular matrix expansion when compared to normoglycemic BN controls (Wallis et al., 
2008). To characterise the architecture of renal gene transcription that may account for these 
renal structural changes and for proteinuria that segregates in a GKxBN F2 cross (Nobrega et 
al., 2009), we applied an eQTL strategy to map genetic loci linked to quantitative variations 
in the abundance of renal transcripts in the GKxBN F2 offspring previously used for diabetes 
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QTL analysis (Gauguier et al., 1996). Genotypes at over 255 framework markers typed in the 
cross were used to impute allele probabilities and construct a map of 898 marker positions 
(2.5 cM spacing between markers). These were used to test for linkage to detectable Illumina 
array signals in each of the 123 F2 rats as previously described (Kaisaki et al., 2016). 
Genome sequencing of the GK/Ox strain (Atanur et al., 2013) allowed us to exclude data 
from Illumina oligonucleotides for 757 genes containing genetic polymorphisms between GK 
and BN (Kaisaki et al., 2016), which may alter binding between probes and the 
oligonucleotides (Alberts et al., 2007), resulting in spurious eQTLs or questionable lack of 
genetic linkage to the corresponding transcripts. As previously observed in adipose tissue 
eQTLs mapped in the same cross (Kaisaki et al., 2016), over 40% of probes with DNA 
polymorphisms gave significant eQTL signals (LOD>10), which deviated from the 
distribution eQTL significance when all oligonucleotides were considered (Figure 2). After 
filtering out probes with low intensity signal a total of 15759 transcripts were considered for 
linkage analyses. 
We identified a total of 2526 eQTLs at FDR<0.05 (Table 1), including 2252 (89%) linked to 
transcripts localised to a single genomic position in the rat genome assembly (RGSC3.4, 
Ensembl release 69) (Table S1). Analysis of eQTL statistical significance showed that 509 
eQTLs (20.1%) can be detected with high confidence (LOD>10) (Figure 3A, Table S1). 
Chromosome distribution of eQTLs showed that 11% of genes on average on each 
chromosome were regulated by eQTLs in the cross (Table 1). An excess of eQTLs was 
detected on chromosomes 5 (27% of genes were associated with an eQTL) and 9 (23% of 
genes were associated with an eQTL) (Table 1). 
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 Genetic mapping of local and distant renal gene transcription regulation in (GKxBN) 
F2 rats 
To assess gene transcription regulation through cis- and trans-mediated genetic effects, we 
compared the genomic positions of transcripts and linked marker loci showing the strongest 
evidence of significant linkage (Figure 3B). A total of 1141 eQTLs (46%) accounted for 
linkage between markers and transcripts mapped to different chromosomes, which 
unambiguously underlie trans-mediated mechanisms of gene transcription regulation (Table 
1; Table S1). The remaining 1356 eQTLs mapped to chromosomes where the linked 
transcripts were encoded, including 1283 eQTLs linked to genes assigned to a unique 
position in the rat genome assembly. A high proportion of these eQTLs were within 10Mb 
(n=1029, 80.3%) or 5Mb (n=788, 61.4%) of the linked transcripts, which could underlie cis-
regulatory mechanisms of gene transcription (Figure 3B, Table S1). The mean LOD score for 
statistically significant eQTLs was 8.32±8.65 (SD) and there was an inverse relationship 
between eQTL significance and frequency (Figure 3C). eQTLs localised in the close vicinity 
to the linked transcripts, which are most likely regulated in cis, showed the highest proportion 
of statistically significant linkage (Figure 3D). Polygenic control of the expression of 133 
genes was suggested when two or more eQTLs were linked to the same gene (Table S1). 
Kidney eQTLs were generally evenly distributed across the genome (Figure 3E). However, 
we noted an excess of trans-mediated eQTLs on chromosomes 5 (n=252) and 9 (n=111), 
which accounts for the above mentioned high number of eQTLs on chromosomes 5 (n=379) 
and 9 (n=175) (Table 1). This can be explained by eQTL clustering in regions of 
chromosomes 5 (50-55cM; 120.3-132.3Mb) and 9 (79.5-84.5cM; 99.2-104.4Mb), which 
control the expression of 165 genes (chromosome 5 eQTLs) and 80 genes (chromosome 9 e 
QTLs) generally regulated in trans (Figure 3E; Table S1). GK genotypes at the eQTL hotspot 
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on chromosome 5 were predominantly associated with downregulated expression of an 
important proportion of eQTL genes (129/165; 78%), suggesting that this phenomenon may 
have genuine biological relevance and reflect the existence of a master regulator of gene 
transcription at this locus. 
Genetic analysis of the renal gene transcriptome identifies sex and cross direction effects 
The design of the experimental cross combining male and female F2 hybrids originating from 
GK females or GK males (Figure 1) allowed us to detect sex and cross direction specific 
patterns of gene expression for 516 and 209 kidney eQTLs, respectively (Table 1; Table S2). 
eQTLs showing cross direction effects (CDE) were evenly distributed across the genome 
(Figure 3F,G) with an average frequency of 0.9% of genes impacted by CDE, and few were 
highly significant (maximum interactive LOD = 20.4) (Table 1; Table S2). Even though 
parent-of-origin effects, which may account for parental imprinting, cannot be assessed in our 
experimental setting of an F2 cross, several eQTLs showing evidence of CDE in the GKxBN 
F2 cross were linked to imprinted genes, including Igf2 (LOD = 4.58, P=0.001), Ndn (LOD = 
4.81, P<0.001), Zfat (LOD = 5.52, P<0.001), Tp53 (LOD = 4.85, P<0.001) and Cdk4 (LOD = 
2.93, P=0.049). Interestingly, expression of Igf2, Ndn and Tp53 was regulated by CDE 
eQTLs in the same region of chromosome 2 (98.9-103.9cM), suggesting the existence of a 
regulator of gene imprinting in this region.  
In contrast to CDE eQTLs, instances of strongly significant linkages were found for sex-
specific eQTL effects (maximum interactive LOD = 104.7) (Table S2). Sex-specific and CDE 
eQTLs were mutually exclusive. Only one locus on chromosome 4 exhibited both sex-
specific effects (LOD = 3.04) and CDE (LOD = 2.92) trans-mediated linkage with the gene 
Trak2. Few eQTLs detected in the full F2 population combining both males and females 
showed evidence of significant CDE (Akr1c2, Dbndd1, F2, Ptpro). In contrast, a relatively 
large number of sex-specific eQTLs, generally regulated in cis were also significant in the 
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full F2 population (Akr1b7, Ank2, Armc3, Ifitm6, LOC494499, LOC500300, LOC684289, 
Neurl2, Nfkbia, Pou4f1, RGD1309350, RGD1559948, RGD1562107, RGD1563820, 
RGD1564419, RGD1564696, RGD1565387, RGD1566401, Scgb1c1, Slc22a13, Sparcl1, 
Spink8, Tgfb2). 
The vast majority of eQTLs showing CDE were unambiguously mediated in trans (Figure 
3G), whereas the most significant sex-specific eQTLs (LOD>10) were predominantly linked 
to genes mapped to the same chromosome (25/30; 83%) and often localised in the close 
vicinity (<10Mb) of linked transcripts (19/30; 63%), suggesting cis-mediated gene expression 
regulation (Table S2). Sex-specific eQTLs were found on all rat chromosomes (Figure 3H) 
with an average of 2.2% showing such effect across the genome (Table 1). However, when 
gene density of individual chromosome was considered, we noted a much stronger proportion 
of genes showing a sex-specific eQTL pattern on chromosomes 5 (n=116; 8.3%), 9 (n=90; 
11.8%) and 17 (n=65; 9.3%) (Table 1; Table S2). Overall, 52.6% of sex-specific eQTLs were 
localised on chromosomes 5 (22.5%), 9 (17.5%) and 17 (12.6%) (Table 1; Table S2; Figure 
3H) and were organised in clusters in the centromeric and interstitial regions of chromosome 
5 (0-2.5cM, 0-5.8Mb, n=27 and 25-32.5cM, 53.1-68.2Mb, n=53), at the telomeric end of 
chromosome 9 (69.9-84.5cM, 90.5-104.4Mb, n=71) and in the interstitial regions of 
chromosome 17 (36.1-48.6cM, 53.0-80.2Mb, n=45) (Figure 3I; Table S2). GK alleles at the 
sex-specific eQTLs in the centromeric region of chromosome 5 (0-2.5cM) were 
predominantly associated with upregulated gene expression (21/27), whereas they were 
associated with downregulated gene expression on chromosome 9 (47/71). 
eQTL-based pathway analysis underscores the involvement of immunological processes 
and drug metabolism in the diabetic kidney 
To identify biological consequences of diabetes and segregating GK/BN polymorphisms 
across the rat genome on renal transcriptional changes, we carried out pathway enrichment 
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analysis of genes under eQTL control in F2 hybrids. A total of 40 biological pathways were 
significantly altered, including primarily mechanisms related to drug and xenobiotic 
metabolism by cytochrome P450 and also various immunological functions covering 
autoimmune diseases (thyroid and graft versus host diseases, type 1 diabetes, rheumatoid 
arthritis) and cellular immune and inflammatory processes (e.g. antigen processing and 
presentation, phagosome) (Table 2). Metabolic pathways were also significantly affected, 
including bile acids, pentose and glucuronate, amino acids (alanine, aspartate, glutamate, 
valine, leucine, isoleucine, selenocompounds), arachidonic acid, butanoate, ketone bodies and 
vitamins (ascorbate, vitamin B6, retinol, folate). Altered processes related to cell adhesion, 
O-glycan biosynthesis and nitrogen metabolism may contribute to impaired renal structural 
and functional regulation. 
eQTL genes contributing to the top ranking pathway (drug metabolism, KEGG 982) included 
aldehyde oxidases (Aox1, Aox3l1), cytochromes P450 (Cyp2c11, Cyp2d1, Cyp2d4, Cyp2d5, 
Cyp2e1), flavin containing monooxygenases (Fmo1, Fmo2, Fmo4, Fmo5), glutathione S-
transferases (Gsta4, Gsta5, Gstm2, Gstm4, Gstp1, Gstt1, Gstt2) and UDP 
glucuronosyltransferases (Ugt1a1, Ugt1a7c, Ugt2b10, Ugt2b15, Ugt2b17, Ugt2b37) (Table 
S1). The eQTL genes for these glutathione S-transferases and several UDP 
glucuronosyltransferases also accounted for the enrichment of the metabolism of xenobiotics 
by cytochrome P450 pathway (KEGG 980), and eQTL genes for these cytochromes P450 and 
these UDP glucuronosyltransferases contributed to the retinol metabolism pathway (KEGG 
830). 
eQTLs linked to RT1 class I and II genes (RT1-A2, RT1-CE5, RT1-CE10, RT1-CE15, RT1-
CE16, RT1-Da, RT1-DMa, RT1-DMb, RT1-Ha, RT1-M3-1, RT1-M10-1, RT1-N2, RT1-N3, 
RT1-CE5) dominated the enrichment of the antigen processing and presentation pathway 
(KEGG 4612). eQTLs for all these RT1 genes, along with RT1-T24-4, lysosomal H+ 
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transporting ATPases (Atp6ap1, Atp6v0a4, Atp6v0e1, Atp6v1d, Atp6v1g3) and tubulins 
(Tuba4a, Tubb2b, Tubb3, Tubb5) accounted for the enrichment of the phagosome pathway 
(KEGG 4145). 
Results from our genome-wide functional analysis of the genetic control of renal gene 
transcription provide a comprehensive landscape of altered biological functions in the 
diabetic kidney and underline the high level of complexity of coordinated regulations of 
molecular processes contributing to renal pathological mechanisms in diabetes in the GK rat. 
Kidney and adipose tissue transcriptomes exhibit tissue specific eQTL features 
To investigate biological functions consistently affected in different tissues in diabetes in the 
GK rat, we compared architectural and functional features of kidney eQTLs to previously 
reported adipose tissue eQTLs mapped in animals of the same GKxBN F2 cross using strictly 
identical experimental and analytical procedures (Kaisaki et al., 2016). We identified 
approximately the same number of eQTLs in kidney (2526) and adipose tissue (2735) in the 
cross (Table S3). Hotspots of eQTLs mostly mediated in trans were identified in both tissues, 
but they were detected on different chromosomes in adipose tissue (chromosomes 1, 7 and 
17) and kidney (chromosome 9), and in different regions of chromosome 5 in adipose tissue 
(57.5–62.5cM) and kidney (0-2.5cM and 25-32.5cM). At the gene level, nearly 20% 
(496/2526, p = 6 x 10-4, one-sided Fisher’s Exact Test) of predominantly locally regulated 
(n=414) kidney eQTLs, were also significant in adipose tissue in the cross (ie. eQTL mapped 
within 15cM in the two tissues and consistent allelic effect on gene expression changes), 
which reveal conserved molecular mechanisms in the two tissues. There were good 
correlations between kidney and adipose tissue for both the magnitude of the allelic effects 
(Figure 4A) and LOD scores (Figure 4B) at the common eQTLs. In contrast, only few 
genuine trans-mediated eQTLs were conserved in the two tissues (Table S4). 
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Sex-effects and CDE were also observed in adipose tissue eQTLs (Table S3). However, we 
did not identify strong excess of sex-specific adipose tissue eQTLs on any chromosome in 
contrast to our observation on chromosomes 5 and 9 in kidney. In the vast majority of cases 
sex-specific and CDE eQTLs identified in the adipose tissue trancriptome were mutually 
exclusive (Table S5). Only 10 genes showed both sex-effects and CDE (Gper, Olr241, 
LOC501102, LOC501113, Ppic, Ppp4c, RGD1564266, Rtp3, Setdb2, Wdr24), but only two 
(Gper, LOC501113) were controlled by the same locus. Conserved sex- and cross direction-
specific genetic effects in fat and kidney was observed for only 11 and 10 genes, respectively, 
but the location of the eQTLs was consistent for only two genes (Nfkbia, Rai14) for sex effect 
and one gene (Tarsl2) for cross direction effects (Tables S2 and S5). 
eQTLs drive tissue-specific functional enrichment in kidney and adipose tissue 
To identify organ-specific and shared genetic regulation of biological pathways in diabetes 
transcriptomes, we compared results from GSEA of kidney and adipose tissue eQTLs 
mapped in the GKxBN F2 cross. Eleven of the top 15 biological pathways regulated by 
eQTLs in kidney were also significantly altered in adipose tissue (Table 2). We found 
evidence of conserved biological effects of eQTLs in the two tissues for immunological 
functions, including autoimmune diseases (e.g. thyroid and graft versus host diseases, type 1 
diabetes) and autoimmune or inflammatory mechanisms (e.g. antigen processing and 
presentation, phagosome, allograft rejection), as well as the metabolism of drug metabolism 
by cytochrome P450, butanoate, selenocompounds and several amino acids (alanine, 
aspartate, glutamate, valine, leucine, isoleucine). On the other hand, enrichment of eQTLs for 
genes involved in the metabolism of ketone bodies, steroid hormone, nitrogen, arachidonic 
acid, retinol, and vitamins B6 and C was significant specifically in the kidney, whereas 
enrichment of eQTLs for genes involved in the metabolism of fatty acid and amino acids 
(cysteine, methionine phenylalanine, tryptophan, tyrosine) was specific to the adipose tissue. 
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Common transcriptional regulation of the phagosome pathway (KEGG 4145) in both kidney 
and adipose tissue was mostly driven by shared strongly significant cis-eQTLs (LOD>7) 
linked to RT1-A2, RT1-CE5, RT1-CE10, RT1-CE15, RT1-CE16, RT1-M3-1, RT1-T24-4, 
Cd36 and Dync1li1 (Figure 5A). Other strongly significant eQTL genes contributing to the 
enrichment of this pathway were detected only in kidney (RT1-N3, Atp6v0a4, Ctss, Tubb2b, 
Tlr6) or in adipose tissue (Fcgr2a, RT1-CE12, Clec4m, Atp6v1c1). This pattern of 
overlapping but largely incomplete conservation of eQTL regulation of biological pathways 
between tissues was also observed for the metabolic regulations pathway (KEGG 1100) 
(Figure 5B). Consistent genetic regulation of metabolic regulations was based on only 38 
consistent eQTLs in kidney and adipose tissue that co-localised in the genome and showed 
the same allelic effects on the direction of gene expression changes in the two tissues. The 
remaining eQTLs contributing to the enrichment of metabolic pathways were localised to 
different chromosomes, showed discordant gene expression patterns in the two tissues 
(n=22), or were detected specifically in kidney (n=123) (e.g. Ugt2b, Cyp4a8) or in fat 
(n=114) (e.g. Cyp2e1) (Table S4). 
The valine, leucine and isoleucine degradation pathway (KEGG 280) provided a typical 
example of the complexity of tissue-specific genetic control of gene transcription (Table 3). 
Even though the pathway was consistently significantly enriched in both kidney and adipose 
tissue with similar numbers of contributing genes in the two tissues, the eQTL genes 
responsible for the enrichment showed clear tissue specific expression. Only the eQTL gene 
Bckdhb showed conserved mapping position and consistent genetic regulation of expression 
in kidney and adipose tissue. All other eQTL genes were either tissue-specific or mapped to 
different chromosomal locations in the two tissues. 
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These data illustrate organ-specific genetic regulation of gene transcription patterns and the 
involvement of distinct molecular components regulating the same pathway in different 
tissues in the context of type 2 diabetes and its renal complications. 
Kidney and adipose tissue eQTLs mapped in the GK are conserved in the spontaneously 
hypertensive rat (SHR). 
To test the pathophysiological relevance of our findings, we compared eQTLs mapped in the 
GKxBN F2 cross with those identified in a rat recombinant inbred (RI) panel derived from 
the spontaneously hypertensive rat (SHR) and the BN strain previously used to map eQTLs in 
adipose tissue and kidney (Hubner et al., 2005). Both GK and SHR are models of insulin 
resistance that derive from a similar outbred stock of Wistar rats selected for glucose 
intolerance (GK) (Goto et al., 1976) or high blood pressure (SHR) (Gauguier, 2005). eQTL 
comparisons in the two mapping systems were based on renal and adipose tissue eQTLs 
identified in the SHR:BN RI for 255 (kidney) and 203 (fat) known genes. Of these, 56 kidney 
eQTL genes (22%) and 52 adipose tissue eQTL genes (26%) were conserved in the BNxGK 
F2 cross (Table S6). The effect of GK and SHR alleles on gene transcription was consistent 
for 38 kidney eQTLs (68%) and 36 adipose tissue eQTLs (69%), suggesting shared genetic 
control of the linked genes in the two strains. On the other hand, trans-regulated eQTLs 
identified in RI strains almost systematically mapped to a different chromosome in the F2 
cross and therefore underlie distinct genetic regulation (Table S6). 
To further test eQTL consistency in GK and SHR, we considered genes linked to genetic 
markers localised in a window of 10Mb in the two mapping systems, in order to account for 
differences in mapping resolution of genetic markers in an F2 cross and in RI strains. Using 
this criterion, we identified 24 kidney eQTLs and 17 fat eQTLs that showed evidence of co-
localisation in the two systems (Table 4). Of these, the majority of eQTLs were cis-mediated 
in kidney (n=19; 79%) and fat (n=13; 76%) and three were ambiguous in the F2 cross. We 
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identified only two trans-mediated eQTLs (Nrd1, Sectm1b) conserved in GK and SHR. Five 
genes (Ascl3, Cd36, Dcps, Ilf3, Mrpl4) were linked to eQTLs in the two tissues. In the vast 
majority of cases, the effects of the GK and SHR alleles on the expression of the linked genes 
were consistent. 
These data underline similarities in the genetic regulation of gene transcription in the GK and 
SHR and suggest common genetic etiology of insulin resistance in both models. 
 
Discussion 
We have characterised the genetic architecture and function of the renal transcriptome in 
diabetes in a F2 cross derived from diabetic GK rats and normoglycemic BN controls, which 
we compared to adipose tissue eQTL data in the cross and transcriptome data in a panel of 
recombinant inbred (RI) strains derived from rats of the SHR model of spontaneous 
hypertension associated with insulin resistance and BN controls. We provide mapping and 
functional details of shared and organ-specific genetic regulation of gene expression in 
kidney and adipose tissue in the F2 cross. Similarities in the genetic control of gene 
transcription in the GK and SHR suggest shared disease etiology in these models, and 
provide information on molecular mechanisms and genes involved in insulin resistance and 
renal anomalies in the contexts of chronic hypertension and hyperglycemia. 
Linkage mapping in the cross identified instances of polygenic control of renal transcripts, 
eQTL hotspots and sex-specific and cross direction effects (CDE), which were largely 
distinct to those previously reported in adipose tissue in the same cross (Kaisaki et al., 2016). 
Several of such eQTL features, which are dominated by transcription regulation in trans, 
have been described in many species and experimental settings (Albert et al., 2018; Hasin-
Brumshtein et al., 2016; Kaisaki et al., 2016; Tian et al., 2016). Parent-of-origin effects on 
gene expression cannot be disentangled in F2 progenies and cannot unambiguously explain 
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CDE on eQTLs. Evidence of increased diabetes severity in F1 progenies of GK mothers 
(Gauguier et al., 1994) and the regulation of imprinted genes by CDE eQTLs in the GKxBN 
F2 cross suggests that parental imprinting affects the phenotypes and gene expression in the 
GK. 
The low effect size of trans-mediated eQTLs is an important issue in assessing genuine sex-
specific and CDE eQTLs. The impact of CDE on eQTLs has not been addressed in the 
context of an F2 cross. On the other hand, genotype by sex effects have been documented in 
QTL studies, including in the GKxBN F2 cross (Gauguier et al., 1996), and the general 
consensus is that they have a modest effect on eQTLs (Dimas et al., 2012; Kassam et al., 
2016), so as on many physiological QTLs (Krohn et al., 2014). The definition of cis-mediated 
gene expression regulation and eQTL hotspots, which relies on arbitrary estimates of physical 
distances between genetic markers and linked transcripts (Breitling et al., 2008; Petretto et 
al., 2006), is problematic in experimental crosses and RI strains due to the extensive linkage 
disequilibrium preventing the high resolution mapping required to separate closely linked 
eQTLs. Nevertheless, our present assessment of renal eQTL hotspots and cis-regulated 
eQTLs is consistent with our previous eQTL mapping data in adipose tissue in the GKxBN 
F2 cross, which we validated in congenic series from the same strain combination (Kaisaki et 
al., 2016).  
Data from our previous Illumina microarray-based renal transcriptome analyses in the GK 
(Hu et al., 2009; Wilder et al., 2009) provide experimental validation for a large number of 
kidney eQTLs. About 44% (n=589) of genes differentially expressed in the kidney between 
GK and BN are controlled by eQTLs in the F2 cross. These figures are consistent with our 
adipose tissue transcriptome data which showed that 43% (531/1221) of differentially 
expressed genes between GK and BN corresponded to eQTLs (Kaisaki et al., 2016). Even 
considering the extreme phenotypic and genomic divergence between GK and BN (Atanur et 
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al., 2013; Saar et al., 2008) potentially contributing to gene expression changes, as much as 
26% (n=347) of differentially expressed genes in kidney between GK and Wistar Kyoto 
strains (Hu et al., 2009), which derive from the same outbred Wistar stock and are therefore 
genetically closely related, are renal eQTLs in the GKxBN F2 cross .  
Genome-wide transcriptome profiling allows unbiased and systematic analyses of biological 
pathways. Pathways related to immunological processes, which are believed to play a role in 
type 2 diabetes (e.g. phagosome, cell adhesion molecules, natural killer cell mediated 
cytotoxicity), were significantly altered in both kidney and adipose tissue in the cross. We 
also noted associations with metabolic pathways (bile acids, ketone bodies, steroid hormone, 
arachidonic acid, leucine, isoleucine, valine) relevant to mechanisms involved in type 2 
diabetes and potentially contributing to GK pathophysiology. In particular the branched-chain 
amino acids (BCAAs) leucine, isoleucine and valine are essential amino acids synthesized by 
gut bacteria (Amorim Franco and Blanchard, 2017) and are associated with insulin resistance 
(Newgard et al., 2009) and increased type 2 diabetes risk (Lotta et al., 2016). The 
identification of largely distinct series of eQTL genes independently contributing to BCAA 
metabolism in kidney and adipose tissue in the GKxBN F2 cross demonstrates the tissue 
specific genetic control of a biological function involved in diabetes. It suggests that different 
components of the pathway are expressed in the two tissues or that the pathway is fully 
expressed in the two tissues, but different components are under eQTL control. 
At the gene level, our eQTL data provide information on the genetic control of transcription 
of individual genes that may contribute to phenotypes relevant to type 2 diabetes that we and 
others have mapped to the rat genome in F2 crosses and congenic strains (Bihoreau et al., 
2017). We detected eQTLs for genes known to carry functional variants contributing to 
glucose intolerance QTLs in the GK, including the inositol polyphosphate phosphatase-like 1 
(Ship2, Inppl1) and the insulin degradation enzyme (Ide) (Fakhrai-Rad et al., 2000; Marion et 
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al., 2002). Of direct relevance to this study, our renal eQTL data can assist the identification 
of genes underlying QTLs for proteinuria detected in a GKxBN F2 cross (Nobrega et al., 
2009). The 1.5 LOD confidence intervals around the peaks of maximum linkage of these 
QTLs (approximately 77-120Mb on chromosome 5 and 60-112Mb on chromosome 7; 
RGSC3.4, Ensembl release 69) contain a total of 69 renal eQTLs in our GKxBN F2 cross, 
which represent functional and positional candidates for these proteinuria QTLs in the GK 
rat. Among these, the 16 cis-regulated eQTL genes localised at the proteinuria QTLs (Abca1, 
Ambp, Angptl3, Cdk5rap2, Echdc2, Fkbp15, Fktn, Inadl, Laptm4b, Ly6c, Mysm1, Nipsnap3b, 
RGD1311188, RGD1564131, Rraga, Slc22a22) are particularly relevant since sequence 
variants at the loci alter their expression. Of note, the glycosyltransferase fukutin (Fktn, 
eQTL LOD=8.02, P<0.001) regulates the number and structure of podocytes (Kojima et al., 
2011), and the α-1-microglobulin/bikunin precursor (Ambp, eQTL LOD=14.53, P<0.001) is 
elevated in urines of patients with diabetic nephropathy (Zubiri et al., 2014). The 
identification of renal eQTLs for genes involved in polycystic kidney disease (Pkd2, cis-
effect, LOD=19, P<0.001; Pkdrej, trans-effect, LOD=4.88, P=0.0042) provides molecular 
evidence of the extent of renal anomalies in the GK. 
We identified similarities in eQTLs mapped in the GK and SHR. Both strains exhibit insulin 
resistance and renal anomalies and share an important proportion of genetic polymorphisms 
(Atanur et al., 2013; Saar et al., 2008), which were isolated following a process of phenotype-
based selection of outbred Wistar rats. We tested the hypothesis of conserved genetic 
regulation of transcription in GK and SHR by comparing eQTLs mapped in kidney and 
adipose tissue in both GKxBN F2 rats and SHR:BN RI strains. Similar numbers of eQTL 
were detected in the two tissues in F2 and RI rats (Grieve et al., 2008). In both tissues, we 
identified a high concordance of eQTLs in GK and SHR despite differences (i) in 
maintenance conditions of the animals, (ii) in platforms used for transcriptome analyses 
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(Illumina beadchips in F2 rats, Affymetrix arrays in RI strains), (iii) in statistical methods 
applied to eQTL mapping and (iv) in genotype frequencies (3 genotypes in the F2 cross and 
either SHR or BN homozygous genotypes at all loci in RI). The latter resulted in differences 
in genetic mapping resolution in the F2 and RI panels, making comparisons of cis- and trans-
mediated effects difficult in the two populations. 
In strong support to our hypothesis of common genetic factors contributing to disease 
phenotypes in GK and SHR or SHR-related strains (SHRSP, SHHF), we identified eQTLs in 
the GK for three genes that are central to SHR etiopathogenesis, including the angiotensin I 
converting enzyme (Ace), which was the strongest candidate in the initial genetic study in the 
SHR (Hilbert et al., 1991), the Cd36 protein (Aitman et al., 1999) and the epoxide hydrolase 
2 (Ephx2), which is associated with heart failure (Monti et al., 2008). We previously reported 
evidence of massive downregulated renal expression of Ephx2 in the GK when compared to 
both BN rats (expression fold change: -11.7, P=2.7x10-26) and Wistar Kyoto rats (expression 
fold change: -9.1, P=1.1x10-24) (Hu et al., 2009). We demonstrate here the strong significance 
of the genetic control of its expression in the GKxBN F2 cross (LOD=91.1), where the GK 
alleles at the Ephx2 locus are associated with downregulated Ephx2 transcription. 
Furthermore, we identified renal eQTLs in the GKxBN F2 cross for genes directly related to 
Ephx2 function, including Ephx1 (LOD=4.3) and Ephx4 (LOD=5.2), where the GK alleles 
are associated with transcription downregulation. According to the mitigating effects of 
Ephx2 inactivation on renal injury induced by hyperglycemia in mice (Bettaieb et al., 2017), 
inhibition of its expression in the GK may underlie compensatory mechanisms to prevent 
renal dysfunction. 
eQTL genes in the GK rat provide functional information relevant to the pathogenesis of 
nephropathy in type 2 diabetes and insulin resistance in humans. Compared to other chronic 
diseases, large scale genetic studies of diabetes kidney disease have provided little consistent 
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clues and replicated genes underlying the cause of the disease, even in the largest population 
study (van Zuydam et al., 2018). This situation underscores the importance of functional data 
derived from preclinical models. Knowledge of synteny conservation between rat and human 
genomes (Wilder et al., 2004) can be used to exploit renal eQTL data produced in the rat to 
annotate the function of positional candidate genes in genomic regions linked to diabetic 
nephropathy in humans (Imperatore et al., 1998). Renal eQTL data in the GK can also 
provide direct functional information to risk genes for kidney disease phenotypes identified 
through GWAS. Associations to glomerular ﬁltration rate were identified for the human 
homologs of renal eQTL genes encoding the DEAD box polypeptide 1 (Ddx1) (cis-mediated, 
LOD=10.89, P<0.001), dipeptidase 1 (Dpep1) (trans-mediated, LOD=3.97, P=0.039), jun D 
proto-oncogene (Jund) (cis-mediated, LOD=7.01, P<0.001), LDL receptor-related protein 2 
(Lrp2) (cis-mediated, LOD=5.38, P=0.003), myopalladin (Mypn) (trans-mediated, 
LOD=4.08, P=0.027), neuregulin 1 (Nrg1) (trans-mediated, LOD=4.76, P=0.009), origin 
recognition complex subunit 4 (Orc4) (LOD=4.07, P=0.027), tyrosine phosphatase receptor 
O (Ptpro) (cis-mediated, LOD=13.43, P<0.001) and xylulokinase, (Xylb) (cis-mediated, 
LOD=8.25, P<0.001) (Morris et al., 2019; Pattaro et al., 2016). The association with PTPRO 
was significant in diabetic individuals. Suggestive association was also reported between the 
human homolog of the trans-mediated renal eQTL gene Abcc8 (LOD= 4.47, P=0.007) and 
diabetic nephropathy in patients with type 2 diabetes (Jeong et al., 2019). Finally, the 
involvement of EPHX2 in diabetic nephropathy was suggested in a case control study in type 
2 diabetic patients (Ma et al., 2018). 
Interestingly, loci associated with IgA nephropathy in humans (Kiryluk et al., 2014; Yu et al., 
2011; Zhou et al., 2014) contain homologs of kidney eQTL genes in the GK encoding 
integrin alpha X (Itgax) (cis-regulated, LOD=8.86, P<0.001), myotubularin related protein 3 
(Mtm3) (trans-regulated, LOD= 3.95, P=0.04) and tumor necrosis factor 13 (Tnfsf13) (cis-
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regulated, LOD=10.87, P<0.001), suggesting that the GK strain exhibits a broad spectrum of 
disease phenotypes and that the GK eQTL data can contribute to enhance knowledge of 
molecular mechanisms involved in a wide range of human disorders. 
Conclusions 
GWAS of diabetes kidney disease have yet to deliver consensus causative genes of strong 
effect size accounting for its genetic etiology in humans. Our data provide original 
information on altered genetic control of renal genes and biological pathways in a preclinical 
model of type 2 diabetes, which spontaneously develops renal anomalies relevant to diabetes 
nephropathy. Conserved genetic control of transcription in kidney in diabetic GK rats and in 
the SHR model of hypertension associated with insulin resistance, in particular for genes 
causing disease phenotypes in the SHR, suggests common disease etiopathogenesis in the 
two strains. Our data may therefore have broad applications in the definition of molecular 
targets and pathways of renal structural and functional anomalies in humans beyond diabetes 
nephropathy.  
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Tables 
Table 1. Overview of kidney eQTLs detected in GKxBN F2 hybrids. Statistical models were 
applied to map eQTL effects using sex and cross as additive covariates (additive model), as 
well as eQTLs that show sex-specificity (Sex interactive) and cross direction effect (CDE).  
The total number of eQTLs detected is given for each chromosome. Cis-regulated eQTL are 
those mapped within 10Mb of the linked transcript. Genetic effects were defined as trans-
regulated eQTLs when eQTL markers and target transcripts map to different chromosomes. 
Chromosome length and number of protein-coding genes are based on ENSEMBL 
annotations of the rat genome (RGSC3.4, Ensembl release 69). Full details of genes 
associated with eQTLs are given in Table S1. Details of comparative analyses with published 
adipose tissue eQTLs mapped in the same cross (Kaisaki et al., 2016) are in Tables S4 and 
S5. 
chr Length (Mb) Gene density eQTLs Frequency Cis Trans Sex-specific CDE 
1 267.9 3030 292 0.10 105 119 35 17 
2 258.2 1488 156 0.10 79 44 18 15 
3 171.1 1810 118 0.07 61 40 29 9 
4 187.1 1501 173 0.11 65 82 27 17 
5 173.1 1405 379 0.27 89 252 116 28 
6 147.6 960 96 0.10 46 29 17 6 
7 143.0 1390 162 0.12 60 87 11 4 
8 129.0 1241 186 0.15 82 91 18 16 
9 113.4 762 175 0.23 41 111 90 18 
10 110.7 1722 132 0.08 87 32 9 5 
11 87.8 615 40 0.07 13 16 9 6 
12 46.8 606 79 0.13 36 38 3 10 
13 111.2 699 72 0.10 32 33 10 3 
14 112.2 796 83 0.10 37 40 3 7 
15 109.8 818 49 0.06 18 23 8 10 
16 90.2 653 57 0.09 27 23 21 14 
17 97.3 700 65 0.09 43 11 65 5 
18 87.3 550 40 0.07 23 8 8 2 
19 59.2 585 54 0.09 25 20 7 4 
20 55.3 621 90 0.14 56 29 11 13 
X 160.7 1028 28 0.03 4 13 0 0 
Total 2718.9 22980 2526 0.11 1029 1141 515 209 
  
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
D
M
M
 •
 A
cc
ep
te
d 
m
an
us
cr
ip
t
Table 2. KEGG pathways significantly affected in kidney transcriptomes in the GKxBN F2 cross. Data were analysed with sex and cross 
as additive covariates. Data were compared to pathways altered in adipose tissue transcriptome in the same cross and reported in (Kaisaki et al., 
2016). Details of pathways can be found at http://www.genome.jp/kegg/. The top 15 pathways in each tissue are highlighted. ns, not statistically 
significant. 
KEGGID Term Size Kidney Adipose tissue 
Count P Rank Count  P Rank 
982 Drug metabolism - cytochrome P450 49 24 <0.01 1 13 0.03 25 
4612 Antigen processing and presentation 60 24 <0.01 2 22 <0.01 5 
980 Metabolism of xenobiotics by cyt P450 40 18 <0.01 3 - ns - 
5416 Viral myocarditis 61 21 <0.01 4 24 <0.01 4 
5332 Graft-versus-host disease 35 14 <0.01 5 17 <0.01 1 
4145 Phagosome 123 34 <0.01 6 41 <0.01 2 
1100 Metabolic pathways 816 163 <0.01 7 167 <0.01 9 
5320 Autoimmune thyroid disease 38 14 <0.01 8 16 <0.01 7 
5330 Allograft rejection 38 14 <0.01 9 16 <0.01 6 
120 Primary bile acid biosynthesis 10 6 <0.01 10 - ns - 
4940 Type I diabetes mellitus 43 15 <0.01 11 18 <0.01 3 
4975 Fat digestion and absorption 25 10 <0.01 12 9 0.03 27 
5140 Leishmaniasis 51 16 0.01 13 19 <0.01 10 
983 Drug metabolism - other enzymes 34 12 0.01 14 - ns - 
40 Pentose and glucuronate interconversions 19 8 0.01 15 - ns - 
65 Butanoate metabolism 19 8 0.01 16 7 0.02 18 
5323 Rheumatoid arthritis 57 17 0.01 17 - ns - 
72 Synthesis and degradation of ketone bodies 6 4 0.01 18 - ns - 
140 Steroid hormone biosynthesis 36 12 0.01 19 - ns - 
53 Ascorbate and aldarate metabolism 17 7 0.01 20 - ns - 
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 910 Nitrogen metabolism 17 7 0.01 21 - ns - 
4514 Cell adhesion molecules 99 25 0.01 22 29 <0.01 8 
514 Other types of O-glycan biosynthesis 25 9 0.01 23 - ns - 
250 Alanine, aspartate, glutamate metabolism 21 8 0.01 24 9 0.01 14 
790 Folate biosynthesis 7 4 0.02 25 4 0.02 20 
4610 Complement and coagulation cascades 53 15 0.02 26 - ns - 
590 Arachidonic acid metabolism 44 13 0.02 27 - ns - 
3320 PPAR signaling pathway 58 16 0.02 28 - ns - 
280 Valine, leucine and isoleucine degradation 36 11 0.02 29 12 0.01 15 
830 Retinol metabolism 36 11 0.02 30 - ns - 
4146 Peroxisome 65 17 0.03 31 - ns - 
4972 Pancreatic secretion 70 18 0.03 32 - ns - 
4640 Hematopoietic cell lineage 51 14 0.03 33 15 0.02 24 
5144 Malaria 33 10 0.03 34 11 0.02 21 
750 Vitamin B6 metabolism 5 3 0.03 35 - ns - 
5150 Staphylococcus aureus infection 29 9 0.03 36 12 0.01 13 
4142 Lysosome 98 23 0.04 37 - ns - 
2010 ABC transporters 34 10 0.04 38 - ns - 
5340 Primary immunodeficiency 21 7 0.04 39 - ns - 
450 Selenocompound metabolism 13 5 0.05 40 5 0.04 28 
270 Cysteine and methionine metabolism 27 - ns - 9 0.03 26 
4512 ECM-receptor interaction 57 - ns - 15 0.05 30 
71 Fatty acid metabolism 33 - ns - 11 0.02 19 
4650 Natural killer cell mediated cytotoxicity 70 - ns - 19 0.02 23 
511 Other glycan degradation 14 - ns - 6 0.02 22 
360 Phenylalanine metabolism 9 - ns - 5 0.01 16 
4970 Salivary secretion 57 - ns - 15 0.05 29 
5322 Systemic lupus erythematosus 59 - ns - 19 <0.01 11 
380 Tryptophan metabolism 27 - ns - 11 <0.01 12 
350 Tyrosine metabolism 16 - ns - 7 0.01 17 
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 Table 3. Detailed analysis of eQTLs contributing to the enrichment of the valine, leucine and isoleucine degradation pathway in kindey and 
adipose tissue in the GKxBN F2 cross. The genetic localisation (cM) of eQTLs showing the stongest linkage to the genes is dervied from their 
mapping position in the genetic map constructed in the GKxBN F2 cross. *The allele from either the Brown-Norway (BN) of the Goto-Kakizaki 
(GK) strain contributing to enhanced gene expression is reported. Chr, chromosome; ns, not statistically significant. 
eQTL gene details Kidney eQTLs Adipose tissue eQTLs 
Symbol Description Chr chr (cM) Allele* LOD P chr (cM) Allele* LOD P 
Abat 4-aminobutyrate aminotransferase 10 10 (4.8) BN 4.76 0.005 - - ns ns 
Acaa1a Acetyl-Coenzyme A acyltransferase 1A 8 - - ns ns 4 (56.3) BN 9.85 <0.001 
      - - ns ns 17 (6.1) GK 3.99 0.046 
Acat3 Acetyl-Coenzyme A acetyltransferase 3 1 - - ns ns 1 (81.9) BN 4.09 0.022 
Aldh1a1 Aldehyde dehydrogenase 1 family, member A1 1 - - ns ns 1 (116.9) BN 7.25 <0.001 
Aldh1a7 Aldehyde dehydrogenase family 1, subfamily A7 1 - - ns ns 1 (116.2) GK 4.52 0.016 
Aldh1b1 Aldehyde dehydrogenase 1 family, member B1 5 5 (30.0) BN 12.54 <0.001 - - ns ns 
Aox1 Aldehyde oxidase 1 9 9 (27.4) BN 3.74 0.046 9 (49.9) GK 20.33 <0.001 
Aox3l1 Aldehyde oxidase 3-like 1 9 6 (45.0) GK 3.93 0.043 - - ns ns 
Bcat2 Branched chain aminotransferase 2, mitochondrial 1 - - ns ns 4 (52.5) BN 5.82 0.001 
Bckdhb Branched chain keto acid dehydrogenase E1, beta 8 8 (55.1) BN 34.3 <0.001 8 (57.5) BN 16.84 <0.001 
Dbt Dihydrolipoamide branched chain transacylase E2 2 - - ns ns 1 (54.4) BN 4.02 0.042 
Echs1 Enoyl CoA hydratase, short chain, 1, mitochondrial 1 - - ns ns 1 (93.4) BN 4.49 0.015 
Hadha Hydroxyacyl-CoA dehydrogenase, alpha subunit 6 9 (69.9) BN 4.15 0.025 6 (10.3) BN 7.34 <0.001 
Hadhb Hydroxyacyl-CoA dehydrogenase, beta subunit 6 6 (10.0) GK 6.74 <0.001 - - ns ns 
Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 2 4 (42.5) GK 3.85 0.043 2 (26.4) BN 5.73 <0.001 
Hmgcs2 3-hydroxy-3-methylglutaryl-CoA synthase 2 2 19 (45) GK 4.79 0.005 - - ns ns 
Ivd Isovaleryl-CoA dehydrogenase 3 3 (69.9) BN 14.42 <0.001 - - ns ns 
Mccc1 Methylcrotonoyl-CoA carboxylase 1 (alpha) 2 2 (56.4) GK 9.8 <0.001 1 (93.4) BN 4.02 0.033 
Pccb Propionyl CoA carboxylase, beta polypeptide 8 8 (70.0) BN 9.16 <0.001 - - ns ns 
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Table 4. Conserved eQTLs mapped in both GKxBN F2 rats and in SHR:BN recombinant inbred (RI) strains. Data are reported for eQTL 
markers co-localised within a window of 10Mb in kidney and white adipose tissue (WAT) in the two mapping panels regardless of cis- and 
trans-mediated effects and allelic effects. The chromosome (Chr) location of the gene and the linked eQTLs are given alongwith the cis- and 
tans-mediated effects when unambiguously determined according to criteria used in the studies. The driving allele corresponds to the allele of 
the strain stimulating the transcription of the eQTL gene. Information of all eQTL genes shared in the two mapping panels in the two tissues are 
given in table S6. 
 
  Gene eQTL GKxBN F2 eQTL SHR:BN RI 
Tissue Symbol Description Chr 
Illumina 
Probe Marker Chr Effect 
Driving 
allele 
Affymetrix 
Probeset Marker Chr Effect 
Driving 
allele 
Kidney Ascl3 Achaete-scute complex homolog 3 1 450735 c1.loc85 1 - BN 1371085_at D1Rat356 1 Cis BN 
Kidney Bphl Biphenyl hydrolase-like 17 5690025 c17.loc22.5 17 Cis GK 1388617_at D17Rat144 17 Cis SHR 
Kidney Cd36 CD36 molecule 4 5550025 D4Got18 4 Cis BN 1386901_at Cd36 4 Cis BN 
Kidney Dcps Decapping enzyme, scavenger 8 3610239 D8Got43 8 Cis BN 1374583_at D8Rat219 8 Cis SHR 
Kidney Dgat2 Diacylglycerol O-acyltransferase 2 1 5270347 D1Mgh20 1 Cis GK 1371615_at D1Rat47 1 Cis SHR 
Kidney Dnmbp Dynamin binding protein 1 3840711 c1.loc130 1 - BN 1372650_at D1Rat235 1 Trans BN 
Kidney Ext2 Exostoses 2 3 4280053 D3Wox33 3 Cis GK 1371611_at D3Rat29 3 Cis BN 
Kidney Fmod Fibromodulin 13 4120168 D13Wox9 13 Cis BN 1367700_at D13N2 13 Trans BN 
Kidney Foxred1 FAD-dependent oxidoreductase 1 8 1580358 c8.loc27.5 8 Cis BN 1376921_at D8Rat219 8 Cis BN 
Kidney Gpm6a Glycoprotein m6a 16 2680131 c16.loc12.5 16 Cis GK 1373773_at D16Mit1 16 Trans SHR 
Kidney Il18 Interleukin 18 8 1660494 D8M9Mit162 8 Cis GK 1369665_at D8Mit12 8 Cis SHR 
Kidney Ilf3 Interleukin enhancer binding factor 3 8 1230142 c8.loc10 8 Cis GK 1387366_at D8Rat68 8 Cis SHR 
Kidney Mfap3 Microfibrillar-associated protein 3 10 7040168 D10Got64 10 Cis GK 1390063_at D10Rat166 10 Cis BN 
Kidney Mrpl4 Mitochondrial ribosomal protein L4 8 870136 c8.loc10 8 Cis BN 1388366_at D8Rat68 8 Cis BN 
Kidney Nfyc Nuclear transcription factor-Y 5 6200487 c5.loc62.5 5 Cis BN 1398268_at D5Rat169 5 Cis BN 
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 Kidney Nup133 Nucleoporin 133 19 6980739 c19.loc37.5 19 Cis BN 1375071_at D19Cebrp150 19 Cis BN 
Kidney Ppm1a Protein phosphatase 1A, 6 7100131 D6Mit8 6 Cis GK 1368859_at D6Rat165 6 Cis SHR 
Kidney Prnp Prion protein 3 2760292 c3.loc62.5 3 Cis GK 1370156_at D3Rat159 3 Cis SHR 
Kidney RGD1306001 Similar to 2210021J22Rik protein 7 1410592 c7.loc80 7 Cis BN 1371749_at D7Rat129 7 Cis BN 
Kidney Rtel1 Regulator of telomere elongation 1 3 2970750 c3.loc107.5 3 Cis GK 1374921_at D3Rat1 3 Cis SHR 
Kidney Sectm1b Secreted and transmembrane 1B 10 6110324 c7.loc7.5 7 Trans GK 1376976_at D7Rat35 7 Trans SHR 
Kidney Snhg8 Small nucleolar RNA host gene 8 16 1580364 D16Rat11 16 Cis GK 1390435_at D16Rat87 16 Cis SHR 
Kidney Tf Transferrin 8 3190022 c8.loc72.5 8 Cis GK 1370228_at D8Rat123 8 Cis SHR 
Kidney Tnfsf12 TNF ligand superfamily member 12 10 2690717 D10Wox12 10 Cis BN 1372503_at Abpa 10 Cis BN 
WAT Aox1 Aldehyde oxidase 1 9 2360093 c9.loc47.5 9 Cis GK 1387376_at D9Rat93 9 Cis SHR 
WAT Ascl3 Achaete-scute complex homolog 3 1 450735 c1.loc85 1 - BN 1371085_at D1Rat356 1 Cis BN 
WAT Bccip BRCA2 and CDKN1A interacting  1 5340408 c1.loc82.5 1 - BN 1371945_at D1Rat47 1 Trans BN 
WAT Ccdc77 Coiled-coil domain containing 77 4 2480270 c4.loc70 4 Cis GK 1390284_at D4Rat202 4 Cis SHR 
WAT Cd36 CD36 molecule 4 5550025 D4Got18 4 Cis BN 1386901_at Cd36 4 Cis BN 
WAT Dcps Decapping enzyme, scavenger 8 3610239 c8.loc30 8 Cis BN 1390185_at D8Rat219 8 Cis BN 
WAT Dpt Dermatopontin 13 5860279 c13.loc27.5 13 - GK 1371732_at D13Rat131 13 Cis SHR 
WAT Eci2 Enoyl-Coenzyme A delta isomerase 2 17 6860193 D17Rat67 17 Cis BN 1388908_at D17Rat144 17 Cis BN 
WAT Fmo3 Flavin containing monooxygenase 3 13 1410309 c13.loc32.5 13 Cis GK 1368304_at D13Mit3 13 Cis SHR 
WAT Fut4 Fucosyltransferase 4 8 3140619 c8.loc7.5 8 Cis GK 1373838_at D8Utr3 8 Cis SHR 
WAT Ilf3 Interleukin enhancer binding factor 3 8 1230142 c8.loc7.5 8 Cis GK 1387366_at D8Rat68 8 Cis SHR 
WAT Itga1 Integrin, alpha 1 2 5220082 c2.loc22.5 2 Cis GK 1387144_at D2Rat201 2 Cis BN 
WAT Mrpl4 Mitochondrial ribosomal protein L4 8 870136 c8.loc7.5 8 Cis BN 1388366_at D8Rat68 8 Cis BN 
WAT Nqo2 NAD(P)H dehydrogenase, quinone 2 17 2680471 c17.loc27.5 17 Cis BN 1374959_at D17Mit2 17 Cis BN 
WAT Nrd1 Nardilysin 1 5 3840202 c1.loc47.5 1 Trans GK 1377340_at D1Rat27 1 Trans SHR 
WAT Prrc1 Proline-rich coiled-coil 1 18 4920452 D18Wox10 18 Cis GK 1374560_at D18Rat55 18 Cis SHR 
WAT Slc7a7 Solute carrier family 7, member 7 15 6770113 c15.loc27.5 15 Cis GK 1387808_at D15Rat6 15 Cis SHR 
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Figure 1. Breeding design applied to map eQTLs in the Goto Kakizaki rat strain. 
Reciprocal genetic crosses between male and female Goto Kakizaki (GK) and Brown 
Norway (BN) rats used to produce individual (GKxBN) F2 rats are illustrated (A) and 
compared to the breeding scheme designed to derive recombinant inbred strains (RI-S) from 
spontaneously hypertensive rats (SHR) and BN rats (B). 
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Figure 2. Distribution LOD scores for renal eQTLs mapped in the GKxBN F2 cross. 
LOD scores are plotted against the proportion of eQTLs detected with all Illumina 
oligonucleotides (blue line) and those containing DNA variation between GK and BN strains 
(red line). 
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Figure 3. Kidney eQTL architecture in GKxBN F2 hybrids. Genetic positions of 
statistically significant eQTLs (FDR p-value<0.05) are plotted against the LOD scores (A). 
Local and distant eQTLs are illustrated by plotting genetic positions of statistically signiﬁcant 
eQTLs and the genomic position of the linked transcripts (B). Distribution of LOD scores for 
significant eQTLs is shown (C). Genome mapping of pairs of eQTL and linked transcripts 
localised in the same chromosomes was used determine relationships between statistical 
significance of genetic linkage and genomic distances between transcripts and genetic 
markers (D). Mapping data from pairs of transcripts and eQTLs localised to different 
chromosomes illustrate distant (trans) effects of genetic loci on gene transcription and eQTL 
hotspots (arrows) (E). Chromosomal distribution and genome-wide trans-mediated regulation 
of cross direction effect (CDE) (F,G) and sex-specific (H,I) eQTLs are shown. 
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 Chromosomes are color coded on the circle to illustrate the effects of eQTLs mapped to the 
same chromosomes on the expression of distant genes. Arrows indicate genomic regions of 
eQTL enrichment. Details of eQTLs are given in Tables S1 and S2. 
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Figure 4. Comparative analyses of kidney and adipose tissue eQTLs mapped in the 
GKxBN F2 cross. The effect of GK alleles at the eQTLs (Expression ratio, ER) on gene 
expression (A) and eQTL statistical significance (LOD score) (B) in kidney and adipose 
tissue were plotted to illustrate the strong conservation of eQTLs detected in both tissues. 
Full details of statistically significant eQTLs illustrating shared and tissue specific genetic 
regulation of gene expression are given in Table S4. 
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Figure 5. Tissue-specific contribution of eQTL genes to pathways enriched in both 
kidney and adipose tissue. Expression ratio (ER) of eQTL genes contributing to significant 
enrichment of phagosome and metabolic pathways in kidney and white adipose tissue are 
plotted to illustrate tissue specific and conserved effects of segregating GK alleles in the 
GKxBN F2 cross on eQTL gene transcription regulation. Full details of statistically 
significant eQTLs illustrating shared and tissue specific genetic regulation of gene expression 
are given in Table S4. 
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Table S1. Details of kidney eQTLs mapped in the GKxBN F2 cross. The additive model 
taking sex and cross into account was used to assess eQTL statistical significance. Cis-
regulated eQTLs correspond to evidence of significant linkages between markers mapped 
within 10Mb to the linked transcript. The position (Mb) of the genes is based on 
ENSEMBL annotations of the rat genome (RGSC3.4, Ensembl release 69). 
 
 
 
Click here to Download Table S1 
 
 
 
 
 
Table S2. Details of renal eQTLs mapped in the GKxBN F2 cross showing statistical 
evidence of sex or cross direction effects. The position of the markers (cM) and linked 
genes (bp) are based on the genetic map constructed in the cross and ENSEMBL 
annotations of the rat genome (RGSC3.4, Ensembl release 69). chr, chromosome. 
 
 
 
Click here to Download Table S2 
 
 
 
 
 
Table S3. Comparative analysis of eQTLs detected in the kidney and adipose tissue in 
GKxBN F2 hybrids. Statistical models were applied to map eQTL effects using sex and 
cross as additive covariates (additive model), as well as eQTLs that show sex-specificity 
(Sex interactive) and cross direction effect (CDE).  The total number of eQTLs detected 
is given for each chromosome. Cis-regulated eQTL are those mapped within 10Mb of the 
linked transcript. Genetic effects were defined as trans-regulated eQTLs when eQTL 
markers and target transcripts map to different chromosomes. Shared eQTLs were 
significant in both kidney and fat and showed conserved transcriptional effects of GK 
alleles at the eQTL. Chromosome length and number of protein-coding genes are based 
on ENSEMBL annotations of the rat genome (RGSC3.4, Ensembl release 69). Full 
details of genes associated with kidney eQTLs are given in Supplementary Table 2. 
Details of the sex-specific eQTLs and CDE eQTLs in the adipose tissue are 
supplementary table 6. Chrom, Chromosome. &#x002A; Data published in Kaisaki et al., 
G3 6(11):3671-3683, 2016. 
 
 
 
Click here to Download Table S3 
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Table S4. Details of comsistent eQTLs mappedin  kidney and adiposet tissue in the 
GKxBN F2 cross. The additive model taking sex and cross into account was used to 
assess eQTL statistical significance. Cis-regulated eQTLs correspond to evidence of 
significant linkages between markers mapped within 10Mb to the linked transcript. The 
position (Mb) of the genes is based on ENSEMBL annotations of the rat genome 
(RGSC3.4, Ensembl release 69). 
 
 
 
Click here to Download Table S4 
 
 
 
 
 
Table S5. Details of adipose tissue eQTLs mapped in the GKxBN F2 cross showing 
statistical evidence of sex or cross direction effect. The position (Mb) of the markers and 
linked genes are based on ENSEMBL annotations of the rat genome (RGSC3.4, Ensembl 
release 69). Cis-regulated eQTLs correspond to evidence of significant linkages between 
markers mapped within 10Mb to the linked transcript. eQTL genes showing evidence of 
both  sex or cross direction effect are highlighted in green. NS, Not statistically 
significant. 
 
 
 
Click here to Download Table S5 
 
 
 
 
 
Table S6. Comparative analysis of kidney and adipose tissue eQTLs mapped in the 
GKxBN F2 cross and in SHR:BN recombinant inbred strains 
 
 
 
Click here to Download Table S6 
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